- First healthcare product distributor platform to achieve an IPO listing
- Issue Size 1600 Crore
- Facilitated partial exit for PE investors
SBICAPS Value Add
- SBICAPS positioned Entero as a key enabler in India’s healthcare product distribution sector with a differentiated high-growth story
- SBICAPS played a crucial role in converting marquee long-only investors and hand holding the management
throughout the IPO process - SBICAPS leveraged its exceptional domain capabilities in the healthcare sector to lead this successful IPO.
- Deal witnessed strong participation from marquee long only investors in the anchor book including high quality FIIs, Insurance companies, Family offices among others
Company Highlights
- One of India’s largest and fastest growing healthcare product distribution platforms (top three in India in terms of revenue in FY22).
- Track record of inorganic expansion and Integration to grow geographic reach, revenues and scale
- Differentiated business model offering comprehensive and Integrated Commercial and Supply Chain Solutions
- Experienced, committed and qualified founding and professional management team backed by pedigreed healthcare focused investor.